LCA5

Clinical trials for LCA5 explained in plain language.

Never miss a new study

Get alerted when new LCA5 trials appear

Sign up with your email to follow new studies for LCA5, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Doctors test One-Shot gene injection to fight rare blindness

Disease control Recruiting now

This study is testing a new gene therapy called OPGx-001 for people with LCA5, a rare genetic condition that damages the retina and leads to vision loss. A small number of participants will receive an injection of the therapy into one eye to see if it is safe and if it might help…

Matched conditions: LCA5

Phase: PHASE1, PHASE2 • Sponsor: Opus Genetics, Inc • Aim: Disease control

Last updated Mar 20, 2026 14:48 UTC

LCA5

Get alerted when new LCA5 trials appear

Doctors test One-Shot gene injection to fight rare blindness